Recombinant multivalent M protein vaccine
US6063386A · kind A · utility
33Cited by
8References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 1997 |
| Grant date | May 16, 2000 |
| Priority date | — |
| Expiry date | Sep 15, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A recombinant multivalent hybrid protein vaccine against multiple serotypes of group A streptococci that may result in rheumatic fever. The vaccine can also evoke other protective antibodies of the mucosal type DNA sequences e.g. genes which encode the necessary amino acids that carry our the desired epitopes. A method of vaccination against streptococcal infections and compositions for carrying out the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.